Currently, ThermoGenesis Holdings Inc. [THMO] is trading at $5.08, up 24.51%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The THMO shares have gain 47.25% over the last week, with a monthly amount glided 24.82%, and seem to be holding up well over a long-time horizon.
From Robots to Self-Driving Cars: 5 AI Stocks to Consider for Your Portfolio
The artificial intelligence (AI) revolution is already here and it's about to change everything we know about everything. With the global market for AI projected to grow from $137 billion in 2022 to over $1.81 trillion by 2030, there's never been a better time to invest in this burgeoning industry. That's why we've compiled a list of the Top 5 AI Stocks to Buy for 2023. These companies are at the forefront of the AI revolution, and have the potential to deliver huge returns to investors like you.
Get our free report, "Top 5 AI Stocks to Buy for 2023".
Sponsored
On 11, January 2023, ThermoGenesis Regains Compliance with Nasdaq Minimum Bid Price Requirement. In a post published today on Yahoo Finance, ThermoGenesis Holdings, Inc. (NASDAQ: THMO) (the “Company”), a market leader in automated cell processing and point-of-care, autologous cell-based therapies, today announced it has received notice from The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with Nasdaq’s minimum bid price for continued listing on the Nasdaq Capital Market set forth in Nasdaq Listing Rule 5550(a)(2) (“Min Bid Price Rule”).
From an analyst’s perspective:
Previously, Maxim Group downgraded its rating to Hold on December 22, 2015. On November 17, 2015, Maxim Group reiterated its Buy rating and revised its price target to $1 on the stock. H.C. Wainwright upgraded its rating to a Buy but stick to its price target of $2 on September 21, 2015. H.C. Wainwright downgraded its rating to a Neutral. H.C. Wainwright started tracking with a Buy rating for this stock on June 26, 2014, and assigned it a price target of $5. In a note dated April 24, 2014, Maxim Group initiated an Buy rating and iterated a target price of $7 on this stock.
This stock has fluctuated between a low of $2.67 and a high of $41.85 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $45.00 within the next 12 months. ThermoGenesis Holdings Inc. [NASDAQ: THMO] shares were valued at $5.08 at the most recent close of the market. An investor can expect a potential return of 785.83% based on the average THMO price forecast.
Analyzing the THMO fundamentals
Recent quarter sales for ThermoGenesis Holdings Inc. [NASDAQ:THMO] were 2.12 billion which represents -34.40% decline. Gross Margin for this corporation currently stands at +32.97% with Operating Margin at -77.80%, Pretax Margin comes in at -127.82%, and Net Margin reading is -122.43%.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 4.28 points at the first support level, and at 3.47 for the second support level. However, for the 1st resistance point, the stock is sitting at 5.58, and for the 2nd resistance point, it is at 6.07.
ThermoGenesis Holdings Inc. [THMO] reported earnings per share of -$0.22 for its fiscal quarter that ended on 12/30/2021. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.06/share, meaning a difference of -$0.16 and a surprise factor of -266.70%. By comparison, the stated earnings for the previous quarter ended on 9/29/2021 were -$0.15 per share as compared to estimates of -$0.08 per share, a difference of -$0.07 representing a surprise of -87.50%.
Ratios To Look Out For
To put it in perspective, the Current Ratio for ThermoGenesis Holdings Inc. [NASDAQ:THMO] is 1.00. Also, the Quick Ratio is 1.51, while the Cash Ratio stands at 1.15. Considering the valuation of this stock, the price to sales ratio is 1.28, the price to book ratio is 3.14.